Search Results

Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-α/δ activation and increased mitochondrial fatty acid oxidation

Authors: Løvås; Røst; Skorve; Ulvik; Gudbrandsen; Bohov; Wensaas; Rustan; Berge; Husebye

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 4, April 2009 , pp. 304-314(11)

Publisher: Blackwell Publishing

Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16

Authors: Yokoyama, H.; Oishi, M.; Kawai, K.; Sone, H.

Source: Diabetic Medicine, Volume 25, Number 12, December 2008 , pp. 1426-1432(7)

Publisher: Blackwell Publishing

Quality of life in hypertension management using olmesartan in primary care

Authors: Schmidt, André C; Bramlage, Peter; Limberg, Roger; Kreutz, Reinhold

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 10, July 2008 , pp. 1641-1653(13)

Publisher: Informa Healthcare

LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat

Authors: Figarola, J.; Loera, S.; Weng, Y.; Shanmugam, N.; Natarajan, R.; Rahbar, S.

Source: Diabetologia, Volume 51, Number 5, May 2008 , pp. 882-891(10)

Publisher: Springer

Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke

Authors: Sharobeem, K. M.; Patel, J. V.; Ritch, A. E. S.; Lip, G. Y. H.; Gill, P. S.; Hughes, E. A.

Source: International Journal of Clinical Practice, Volume 61, Number 11, November 2007 , pp. 1824-1828(5)

Publisher: Blackwell Publishing

Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors

Authors: Fornengo, P.; Bosio, A.; Epifani, G.; Pallisco, O.; Mancuso, A.; Pascale, C.

Source: Diabetic Medicine, Volume 23, Number 7, July 2006 , pp. 775-779(5)

Publisher: Blackwell Publishing

Determinants of risk factors of atherosclerosis in the postinfarction period: The Tallinn MI Study

Authors: Aasvee, K.; Jauhiainen, M.; Kurvinen, E.; Tur, I.; Sundvall, J.; Roovere, T.; Baburin, A.

Source: Scandinavian Journal of Clinical and Laboratory Investigation, Volume 66, Number 3, April 2006 , pp. 191-199(9)

Publisher: Informa Healthcare

Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control

Authors: Ahn, Chul Woo; Kim, Chul Sik; Nam, Jae Hyun; Kim, Hai Jin; Nam, Ji Sun; Park, Jong Suk; Kang, Eun Seok; Cha, Bong Soo; Lim, Sung Kil; Kim, Kyung Rae; Lee, Hyun Chul; Huh, Kap Bum

Source: Clinical Endocrinology, Volume 64, Number 4, April 2006 , pp. 444-449(6)

Publisher: Blackwell Publishing

A < 1.7 cM interval is responsible for Dmo1 obesity phenotypes in OLETF rats

Authors: Watanabe T.K.; Okuno S.; Yamasaki Y.; Ono T.; Oga K.; Mizoguchi-Miyakita A.; Miyao H.; Suzuki M.; Momota H.; Goto Y.; Shinomiya H.; Hishigaki H.; Hayashi I.; Asai T.; Wakitani S.; Takagi T.; Nakamura Y.; Tanigami A.

Source: Clinical and Experimental Pharmacology and Physiology, Volume 31, Numbers 1-2, January 2004 , pp. 110-112(3)

Publisher: Blackwell Publishing

Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport

Authors: Dullaart, R. P. F.; van Tol, A.

Source: Diabetic Medicine, Volume 18, Number 6, June 2001 , pp. 509-513(5)

Publisher: Blackwell Publishing

Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control

Authors: Tan C.E.; Chew L.S.; Chio L.F.; Tai E.S.; Lim H.S.; Lim S.C.; Jayakumar L.; Eng H.K.; Packard C.J.

Source: Diabetes Research and Clinical Practice, Volume 51, Number 2, February 2001 , pp. 107-114(8)

Publisher: Elsevier

Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus

Authors: Björntorp, P.; Holm, G.; Rosmond, R.

Source: Diabetic Medicine, Volume 16, Number 5, May 1999 , pp. 373-383(11)

Publisher: Blackwell Publishing

Endocrinology. Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome

Authors: M.B. Tíra; R. Yalçìn; V. Noyan; I. Maral; M. Yìldìrìm; O. Dörtlemez

Source: Human Reproduction, Volume 14, Number 8, August 1999 , pp. 1949-1952(4)

Publisher: Oxford University Press

Dyslipidaemia and the progression of renal disease in chronic renal failure patients

Authors: Massy Z.A.; Khoa T.N.; Lacour B.; Descamps-Latscha B.; Man N.K.; Jungers P.

Source: Nephrology Dialysis Transplantation, Volume 14, Number 10, October 1999 , pp. 2392-2406(15)

Publisher: Oxford University Press